This announcement is a separate document:
Mesoblast Ltd: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.